HyperFlex Medical announced the successful completion of the first case in its clinical evaluation of the HyperFlex Bunion Correction System.
HyperFlex features a flexible, suture-based implant realigns the metatarsals through a small incision, preserving motion, minimizing trauma, and allowing same-day weight-bearing.
“This first case underscores the need for a more patient-friendly approach,” said Bob Peterhans, CEO of HyperFlex Medical. “HyperFlex offers a less invasive option earlier in the disease process—without compromising alignment or outcomes. We’re excited to see the system in action and grateful to our clinical partners.”
HyperFlex closed a $1.4 million investment in June and received FDA 510(k) marketing clearance in November 2024. The company holds issued patents in the U.S. and Europe.
HyperFlex Medical announced the successful completion of the first case in its clinical evaluation of the HyperFlex Bunion Correction System.
HyperFlex features a flexible, suture-based implant realigns the metatarsals through a small incision, preserving motion, minimizing trauma, and allowing same-day weight-bearing.
"This first case...
HyperFlex Medical announced the successful completion of the first case in its clinical evaluation of the HyperFlex Bunion Correction System.
HyperFlex features a flexible, suture-based implant realigns the metatarsals through a small incision, preserving motion, minimizing trauma, and allowing same-day weight-bearing.
“This first case underscores the need for a more patient-friendly approach,” said Bob Peterhans, CEO of HyperFlex Medical. “HyperFlex offers a less invasive option earlier in the disease process—without compromising alignment or outcomes. We’re excited to see the system in action and grateful to our clinical partners.”
HyperFlex closed a $1.4 million investment in June and received FDA 510(k) marketing clearance in November 2024. The company holds issued patents in the U.S. and Europe.
Copy to clipboard 
